California urges mpox vaccination after more severe clade I case emerges
California is urging high-risk residents to complete both mpox shots after San Francisco’s first clade I case, a hospitalized unvaccinated adult who is improving.

California health officials are urging people at higher risk for mpox to get fully vaccinated now after San Francisco confirmed its first clade I case, involving an unvaccinated adult who was hospitalized and is improving. State officials say the two-dose vaccine protects against both clade I and clade II, can cut the risk of getting mpox by about 86% to 89%, and reaches its strongest protection about two weeks after the second dose.
The warning is aimed squarely at people most likely to encounter the virus or to face worse outcomes if infected, not at the general public in the abstract. San Francisco and California public-health officials say the overall risk remains low for people outside higher-risk groups, but they are pressing for faster vaccination because clade I has been associated with more severe illness than the strain that drove most of the earlier U.S. outbreak.
The San Francisco patient reported close contact with someone who had traveled internationally to an area where clade I mpox is circulating. Health officials confirmed the case on April 14, 2026, and said it is the first clade I infection identified in the city. California said it was the seventh identified clade I case in the state since November 2024, a sign that public-health agencies have been tracking the strain for months rather than treating it as an isolated surprise.
That broader surveillance matters because the United States is still seeing mostly clade II mpox, and the Centers for Disease Control and Prevention has said most U.S. cases continue to occur among people who are unvaccinated or have received only one dose of JYNNEOS. California’s message is shaped by that history: officials do not want to wait for a cluster before pushing vaccination, contact tracing and outreach to people at higher risk.
The stakes are amplified by the global spread of clade I. It has circulated in eastern and central Africa since 2023 and has caused more than 53,000 cases and at least 200 deaths there. In California, public-health teams are now using enhanced surveillance and contact tracing to look for additional cases and prevent further transmission. The message from state and local officials is clear: act early, vaccinate fully, and use the narrow window before more infections take hold.
Know something we missed? Have a correction or additional information?
Submit a Tip

